Trending Stock News

Richard Bernstein Advisors Upped Priceline Grp (PCLN) Position; Sphera Funds Management LTD Upped Its Prothena Plc (PRTA) Holding

Prothena Corporation plc (NASDAQ:PRTA) Logo

Richard Bernstein Advisors Llc increased Priceline Grp Inc (PCLN) stake by 10.58% reported in 2017Q4 SEC filing. Richard Bernstein Advisors Llc acquired 269 shares as Priceline Grp Inc (PCLN)’s stock 0.00%. The Richard Bernstein Advisors Llc holds 2,812 shares with $4.89M value, up from 2,543 last quarter. Priceline Grp Inc now has $92.94B valuation. The stock decreased 0.07% or $1.38 during the last trading session, reaching $1905.64. About 570,074 shares traded or 40.00% up from the average. Booking Holdings Inc. (NASDAQ:PCLN) has 0.00% since April 26, 2017 and is . It has underperformed by 11.55% the S&P500.

Sphera Funds Management Ltd increased Prothena Corp Plc (PRTA) stake by 241.67% reported in 2017Q4 SEC filing. Sphera Funds Management Ltd acquired 145,000 shares as Prothena Corp Plc (PRTA)’s stock rose 2.47%. The Sphera Funds Management Ltd holds 205,000 shares with $7.69 million value, up from 60,000 last quarter. Prothena Corp Plc now has $454.67M valuation. The stock increased 7.28% or $0.8 during the last trading session, reaching $11.79. About 1.87 million shares traded or 104.43% up from the average. Prothena Corporation plc (NASDAQ:PRTA) has declined 31.00% since April 26, 2017 and is downtrending. It has underperformed by 42.55% the S&P500.

Investors sentiment decreased to 1.18 in 2017 Q4. Its down 0.47, from 1.65 in 2017Q3. It dropped, as 29 investors sold PRTA shares while 32 reduced holdings. 28 funds opened positions while 44 raised stakes. 31.32 million shares or 0.27% more from 31.24 million shares in 2017Q3 were reported. Sectoral Asset Mgmt has invested 0.86% in Prothena Corporation plc (NASDAQ:PRTA). Schwab Charles Inv invested 0.01% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA). Carroll Financial invested in 1 shares. Focused Wealth Mgmt reported 6,150 shares. Blackrock has invested 0.01% in Prothena Corporation plc (NASDAQ:PRTA). Cap invested in 0.01% or 1.17M shares. Sandy Spring Commercial Bank has invested 0% in Prothena Corporation plc (NASDAQ:PRTA). Palo Alto Ltd Com stated it has 1.77% in Prothena Corporation plc (NASDAQ:PRTA). Fincl Architects Inc has invested 0% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA). Moreover, Geode Cap Management Lc has 0% invested in Prothena Corporation plc (NASDAQ:PRTA). Oregon-based Hood River Capital Mngmt Limited Co has invested 0.46% in Prothena Corporation plc (NASDAQ:PRTA). Whittier Trust has 0% invested in Prothena Corporation plc (NASDAQ:PRTA). Wellington Management Group Llp stated it has 0.03% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA). Jennison Associates Limited Co holds 0.02% or 416,031 shares. Pointstate Capital Limited Partnership has invested 0.09% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA).

Among 14 analysts covering Prothena Corp (NASDAQ:PRTA), 7 have Buy rating, 0 Sell and 7 Hold. Therefore 50% are positive. Prothena Corp had 42 analyst reports since July 22, 2015 according to SRatingsIntel. RBC Capital Markets downgraded the stock to “Hold” rating in Monday, April 23 report. The firm has “Buy” rating given on Wednesday, November 8 by Cantor Fitzgerald. Barclays Capital initiated it with “Overweight” rating and $60 target in Friday, May 13 report. The stock has “Overweight” rating by Cantor Fitzgerald on Tuesday, April 24. The stock has “Buy” rating by Cantor Fitzgerald on Wednesday, December 20. As per Monday, April 23, the company rating was downgraded by Barclays Capital. The firm earned “Buy” rating on Wednesday, December 21 by SunTrust. The stock has “Buy” rating by BTIG Research on Friday, September 29. Oppenheimer initiated the shares of PRTA in report on Thursday, July 6 with “Buy” rating. Cantor Fitzgerald maintained the shares of PRTA in report on Thursday, February 15 with “Buy” rating.

Sphera Funds Management Ltd decreased Pieris Pharmaceuticals Inc stake by 200,000 shares to 800,000 valued at $6.04M in 2017Q4. It also reduced Axsome Therapeutics Inc stake by 200,000 shares and now owns 301,000 shares. Inotek Pharmaceuticals Corp was reduced too.

Investors sentiment is 1.03 in Q4 2017. Its the same as in 2017Q3. It is flat, as 86 investors sold PCLN shares while 311 reduced holdings. only 96 funds opened positions while 311 raised stakes. 43.90 million shares or 12.31% less from 50.07 million shares in 2017Q3 were reported. Massachusetts-based Crestwood Advsrs Group Ltd Co has invested 1.32% in Booking Holdings Inc. (NASDAQ:PCLN). Bbva Compass State Bank reported 1,471 shares. California-based Capital Global Invsts has invested 0.55% in Booking Holdings Inc. (NASDAQ:PCLN). Legal General Public Limited reported 230,269 shares or 0.29% of all its holdings. Cim Inv Mangement owns 785 shares. Impala Asset Limited Liability Company invested in 0.04% or 667 shares. Hbk Sorce Advisory Ltd Limited Liability Company holds 333 shares. 617 are held by Rosenbaum Jay D. Moreover, Sentry Corporation has 1.41% invested in Booking Holdings Inc. (NASDAQ:PCLN). Addison reported 0.32% stake. Altimeter Capital Mngmt L P, Massachusetts-based fund reported 123,000 shares. Benjamin F Edwards Incorporated reported 40 shares. The Colorado-based Weatherstone Mgmt has invested 0.24% in Booking Holdings Inc. (NASDAQ:PCLN). Tarbox Family Office has invested 0.02% in Booking Holdings Inc. (NASDAQ:PCLN). Harding Loevner Ltd Partnership holds 1.79% or 181,574 shares in its portfolio.

Since December 15, 2017, it had 0 insider purchases, and 7 selling transactions for $10.38 million activity. 295 shares were sold by Tans Gillian, worth $617,762 on Monday, April 16. $7.94 million worth of stock was sold by MILLONES PETER J on Thursday, March 15. 250 shares valued at $505,000 were sold by EPSTEIN JEFFREY E on Monday, March 5.

Among 34 analysts covering Priceline.com (NASDAQ:PCLN), 26 have Buy rating, 0 Sell and 8 Hold. Therefore 76% are positive. Priceline.com had 101 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Hold” rating by Deutsche Bank on Tuesday, October 24. Piper Jaffray maintained the shares of PCLN in report on Tuesday, July 11 with “Buy” rating. The stock of Booking Holdings Inc. (NASDAQ:PCLN) earned “Hold” rating by M Partners on Thursday, December 7. As per Tuesday, November 7, the company rating was maintained by Credit Suisse. The stock has “Neutral” rating by Guggenheim on Wednesday, May 4. Piper Jaffray maintained Booking Holdings Inc. (NASDAQ:PCLN) rating on Friday, August 5. Piper Jaffray has “Overweight” rating and $1625 target. Vetr downgraded it to “Buy” rating and $1351.59 target in Tuesday, August 18 report. The company was maintained on Wednesday, August 5 by RBC Capital Markets. Vetr upgraded the stock to “Strong-Buy” rating in Wednesday, September 2 report. The company was maintained on Friday, August 5 by Deutsche Bank.

Prothena Corporation plc (NASDAQ:PRTA) Ratings Chart

Leave a Reply

Your email address will not be published. Required fields are marked *